Marshall Wace North America’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q3
Sell
-187,088
Closed -$561K 1720
2017
Q2
$561K Buy
+187,088
New +$561K ﹤0.01% 1068
2013
Q4
Sell
-64,649
Closed -$990K 959
2013
Q3
$990K Buy
+64,649
New +$990K 0.03% 346